- Today : 2020.03.29
- D- -206
- The 8th International Congress on Lipid & Atherosclerosis (ICoLA)
-
The 58th Fall Conference of the Korean Society of Lipid & Atherosclerosis
September 5 (Thu) ~ 7 (Sat), 2019
Conrad Seoul Hotel, Korea
Luncheon Symposia
- Page Path
-
- Program
- Luncheon Symposia
*(K) Korean Session
- LUNCHEON SYMPOSIUM 1
-
Sep. 6 (Fri.)
12:10~13:10 - Room 1
more
Chairperson
Cheol Ho Kim (Seoul National University, Korea)
| 12:10-12:30 | Optimizing Risk Reduction Strategies in Patients with Diabetes and Atherosclerotic Cardiovascular Disease Robert S. Rosenson (The Mount Sinai Hospital in New York, USA) | Abstract |
| 12:30-12:50 | The Evidence of Using Metformin as a Treatment for Patients with Type 2 Diabetes Hye Soon Kim (Keimyung University, Korea) | Abstract |
- LUNCHEON SYMPOSIUM 2
-
Sep. 6 (Fri.)
12:10~13:10 - Room 2
more
Chairperson
Hyun Chul Lee (Yonsei University, Korea)
| 12:10-12:40 | The Additional Benefits of Anagliptin Beyond Glycemic Control Jun Hwa Hong (Eulji University, Korea) | Abstract |
- LUNCHEON SYMPOSIUM 3
-
Sep. 6 (Fri.)
12:10~13:10 - Room 3
more
Chairperson
Kwang-Won Kim (Gachon University, Korea)
| 12:10-12:40 | Additional Benefits of Rosuvastatin/Ezetimibe Combination Therapy Yong-ho Lee (Yonsei University, Korea) | Abstract |
- LUNCHEON SYMPOSIUM 4
-
Sep. 6 (Fri.)
12:10~13:10 - Room 4
more
Chairperson
Ho Young Son (The Catholic University of Korea, Korea)
| 12:10-12:30 | Advantages of Rosuvastatin and Ezetimibe Combination Treatment Moo-Yong Rhee (Dongguk University, Korea) | Abstract |
| 12:30-12:50 | Evidence-Based Approach for Ideal Hypertension Management Soon Jun Hong (Korea University, Korea) |
- LUNCHEON SYMPOSIUM 5
-
Sep. 7 (Sat.)
12:10~13:10 - Room 1
more
Chairperson
Hong Kyu Lee (Eulji University, Korea)
| 12:10-12:30 | See the Unseen in Recent Cardiorenal Outcome Trials of T2DM Treatments Soo Lim (Seoul National University, Korea) | Abstract |
| 12:30-12:50 | Treatment Approach for Type 2 Diabetes Considering the Stable Glycemic Control So Hun Kim (Inha University, Korea) | Abstract |
- LUNCHEON SYMPOSIUM 6
-
Sep. 7 (Sat.)
12:10~13:10 - Room 2
more
Chairperson
Dong Soo Kim (Inje University, Korea)
| 12:10-12:50 | Current and Future Lipid Treatment through Recent Key Outcomes Anselm K. Gitt (Ludwigshafen University, Germany) | Abstract |
| 12:50-13:10 | Discussion |
- LUNCHEON SYMPOSIUM 7 The Need for Additional Glucose-lowering Therapies with Proven Long-term Cardiovascular Safety Profiles
-
Sep. 7 (Sat.)
12:10~13:10 - Room 3
more
Chairperson
Yeong Gil Choi (Kyung Hee University, Korea)
| 12:10-12:30 | The Impact of Empagliflozin beyond Glucose Control : from Mechanism to Outcome Stefano Del Prato (University of Pisa, Italy) | |
| 12:30-12:50 | Comprehensive Data from Empagliflozin : How These Results Translate into Routine Clinical Practice? Kausik Ray (Imperial College London, UK) | Abstract |
- LUNCHEON SYMPOSIUM 8
-
Sep. 7 (Sat.)
12:10~13:10 - Room 4
more
Chairperson
Kyoo-Rok Han (Hallym University,Korea)
| 12:10-12:40 | Recent Updates in Hypertension Goals: What Does The Physician Need to Know? Sanjay Rajagopalan (Case Western Reserve University, USA) | Abstract |
- Organized by
-
The Korean Society of Lipid and Atherosclerosis
- Tel : +82-2-3272-5330
- Fax : +82-2-3272-5331
- Email : ksla@lipid.or.kr
- Business Registration Number : 110-82-60956
- Chairman : Joong-Yeol Park
-
Secretariat of ICoLA 2019 │ People & Value, Inc.
- Tel: +82-2-2135-3617, 3618, 3621
- Fax: +82-2-564-2123
- E-mail: secretariat@icola.org
Copyrights 2019 © The Korean Society of Lipid and Atherosclerosis. All rights reserved.